Jefferies Starts Liquidia Technologies (LQDA) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
Needham & Company Starts Liquidia Technologies (LQDA) at Buy
August 20, 2018 6:57 AM EDTNeedham & Company analyst Serge Belanger initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Buy rating and a price target of $30.00.
Belanger commented, "We initiate coverage of Liquidia Technologies (LQDA), a late-stage biopharma developing LIQ861, a differentiated inhaled PAH treatment based on its... More
Cowen Starts Liquidia Technologies (LQDA) at Outperform
August 20, 2018 5:40 AM EDTCowen analyst Ken Cacciatore initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Outperform rating and a price target of $40.00.
The analyst comments "The lead asset is LIQ861 for PAH, an inhaled reformulation of a known active molecule, treprostinil, that is more optimally... More
